- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04299659
Comparison of Four Methods for Entering the Gap Position of Landolt Cs (LC_Entry)
Comparison of Four Methods for Entering the Gap Position of Landolt Cs With Respect to Validity, Retest Reliability, Examination Duration and Test Subject Satisfaction
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The measurement of visual acuity is the most frequent and one of the most important ophthalmological functional investigations. Therefore, it is particularly important to find a measuring procedure with as little input errors as possible.
The 8-position Landolt C (LC) is the internationally accepted, well-standardised optotype for the determination of visual acuity.
Usually, the subjects informs the examiner verbally about the perceived position of each LC. According to the current literature, about 20 to 30 % of the population suffers from a right/left weakness. Furthermore, language barriers are an additional considerable hurdle.
Therefore, it is important to find an input method for the LC gap positions with minimal entry mistakes. In oder to avoid the thresholding procedure and its inherent difficulties, highly supra-threshold (10 times above the previously determined individual central visual acuity threshold) 8-position LCs are presented.
The study compares four input methods for entering of the Landolt C gap positions: a modified numeric keypad, an 8-position rocker switch, a modified TV remote control and voice/verbal feedback.
Each subject will perform all four input methods, with 2 test runs of 16 Landolt C presentations, each. A forced-choice method will be applied, i.e. the test is not continued until the test person has responded ot each single presentation. Regardless of whether the entry was correct or incorrect, the next Landolt C is displayed.
The optotypes are presented using modified version of the Freiburg Visual Acuity and Contrast Test (FrACT), which allows to present the 8-position Landolt Cs in a standardized way on a video display unit (VDU).
The sequence of the input methods is randomized. This study is carried out in a "within-subject design", i.e. all test persons go through all test conditions and serve as their own controls.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Deutschland
-
Aalen, Deutschland, Germany, 73430
- Ulrich SCHIEFER
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age: ≥ 18 years
- Informed consent
- (Distance) visual acuity with best correction: ≥ 0.8
- (Distant) ametropia: ≤+8.0 Diopters (spherical equivalent)
- Anisometropia ≤ 3 dpt
- Astigmatism ≤ 2.5 dpt
Exclusion Criteria:
- Prolonged reaction time caused by drugs (medications)/ drugs/alcohol
- Movement disorders (of hands) such as Parkinson's disease
- Indication of amblyopia (strabismus surgery, occlusion therapy etc.)
- Eye movement disorders/double vision
- Defective stereo vision (according to LANG [I] stereo test)
- Presence of a relative afferent pupil defect ("swinging flashlight test)
- Any hint of visual pathway lesion or other chronic or progressive eye disease
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
validity
Time Frame: Through study completion, an average of 3 months
|
Proportion of correct gap position entries in relation to the total number of LC presentations by the four different entry methods
|
Through study completion, an average of 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
retest reliability
Time Frame: Through study completion, an average of 3 months
|
Comparison of the correct gap position entry between first and second test run by the four different entry methods
|
Through study completion, an average of 3 months
|
|
Examination duration
Time Frame: Through study completion, an average of 3 months
|
Comparison of the examination duration of the the four different entry methods and by the first and second run
|
Through study completion, an average of 3 months
|
|
Subjects´ satisfaction
Time Frame: Through study completion, an average of 3 months
|
Subjects´ evaluation (using a questionnaire) for the four different entry methods
|
Through study completion, an average of 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Ulrich Schiefer, M.D., +49 7361 576-4605
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- LC Entry_2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Validation Study
-
University of ValladolidCompleted
-
SunriseCompleted
-
Mayo ClinicBioSpace, Inc.Completed
-
The Mediterranean Institute for Transplantation...Not yet recruiting
-
KU LeuvenRecruiting
-
Cionic, Inc.Completed
-
Meyer Children's Hospital IRCCSRecruiting
-
Inge TetensCompletedValidation StudyDenmark
-
Kyma Medical TechnologiesCompletedHealth Volunteer Validation Study
-
Hacettepe UniversityActive, not recruitingAthletic Performance | Validation StudyTurkey
Clinical Trials on Landolt C entry method
-
University of BaselCompletedVisual AcuitySwitzerland
-
Schiefer UlrichCompletedOphthalmologically Normal SubjectsGermany
-
University of ArkansasTerminatedObesity | PregnancyUnited States
-
Centre Hospitalier Intercommunal CreteilAssociation Clinique Thérapeutique Infantile du val de MarneCompletedRespiratory Infections in Children | Respiratory InfectionFrance
-
NestléNational University Hospital, Singapore; National University, SingaporeCompleted
-
Janssen Research & Development, LLCCompleted
-
University of California, DavisEli Lilly and CompanyCompletedLung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Liverpool School of Tropical MedicineCompletedTuberculosis | DiagnosisBangladesh, Kenya, Brazil, Cameroon, Malawi, Nigeria, Vietnam
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Yale UniversityEisai Inc.CompletedPeripheral T-Cell LymphomaUnited States